Antiviral Therapy

Antiviral therapy in hepatology refers to medications used to treat chronic viral hepatitis B or C infections, aiming to suppress or eliminate the virus and prevent progression to cirrhosis or liver cancer. For hepatitis C, modern direct-acting antiviral drugs can cure the infection in the vast majority of patients within a relatively short course of oral tablets. For hepatitis B, treatment usually involves long-term suppressive therapy rather than a cure, controlling viral replication to reduce liver damage over time. Treatment selection depends on the specific virus genotype, degree of liver damage, and patient factors such as kidney function and other medications.

Antiviral Therapy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Hepatology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 8-24 weeks course (varies by condition). This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes There is no procedural recovery since this is an oral medication-based therapy, though the treatment course itself can last several weeks to months. Most patients tolerate the medication well with minimal disruption to daily activities. Follow-up blood tests after completing treatment confirm whether the virus has been successfully cleared or suppressed.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Antiviral Therapy has a documented success rate of 90-97% for hepatitis C at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.